HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Technology Transfer (STTR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.RFA-NS-20-009 (Source:...
Source: NIDDK Funding Opportunities - October 4, 2019 Category: Endocrinology Source Type: funding
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)
The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.RFA-NS-20-010 (Source:...
Source: NIDDK Funding Opportunities - October 4, 2019 Category: Endocrinology Source Type: funding
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.RFA-NS-20-011 (Source:...
Source: NIDDK Funding Opportunities - October 4, 2019 Category: Endocrinology Source Type: funding
Seeking Comments on Using Fast Healthcare Interoperability Resources for NIH-Supported Research
NIH
is currently accepting public comments on the use of standards for capturing, integrating,
and exchanging clinical data for research purposes (NOT-OD-19-150).
This is a great opportunity to hear more from the community on ways to
strengthen approaches that find, share, and access high-quality patient data,
while also making it more interoperable and reusable. Such goals align with
long-standing NIH
data sharing policies and what was also called for in a
related NIH strategic plan on
data science.
The
Request for Information focuses on the Fast
Healthcare Interoperability Resources (FHIR®) standard (see also NOT-OD-...
Source: NIH Extramural Nexus - September 30, 2019 Category: Research Authors: Mike Lauer Tags: blog Open Mike Uncategorized fast healthcare interoperability resources FHIR request for information Request For Information (RFI) Source Type: funding
NIH Blueprint for Neuroscience Research Education Program on Translational Devices (R25 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-20-003 from the NIH Guide for Grants and Contracts. This FOA solicits Research Education Grant (R25) applications to develop and implement a short course focused on (1) steps required for successful medical device development and translation, (2) common technical and strategic challenges, and (3) best-practices and resources for each stage in the process. Applicants may choose to include an extended mentorship plan if they see fit. The short course should address a broad audience, including senior post-doctoral fellows, independent academic researchers, clinician scientists, and small business...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 20, 2019 Category: Research Source Type: funding
Non-invasive Diagnostics to Improve Gynecologic Health (R43/R44 Clinical Trial Optional)
Funding Opportunity RFA-HD-20-019 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage small businesses to collaborate with scientists and clinicians in the field of gynecologic health to develop, advance, and validate new devices and methods for non-invasive diagnosis and/or screening of endometriosis, adenomyosis, and/or uterine fibroids. Projects supported will aim to shorten the time to diagnosis, decrease the invasiveness of current techniques, and/or improve accessibility, safety, convenience, and costs of diagnosis and/or screening. (Source: NIH F...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 17, 2019 Category: Research Source Type: funding
NIDDK Notice of Participation in PA-19-273, "PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)"
Notice NOT-DK-19-022 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 9, 2019 Category: Research Source Type: funding
Oweesta Native CDFI Loan Funds and Technical Assistance
Oweesta is an intermediary organization that provides financial products and development services for Native Community Development Financial Institutions (CDFIs). The primary goal is to support Native CDFIs so that they have the capacity to assist individuals, businesses, and organizations with financing and technical assistance for the development of small businesses, affordable housing/home ownership, community facilities, financial education programs, and agriculture/food sovereignty in Native communities. Geographic coverage: Nationwide -- First Nations Development Institute, First Nations Oweesta Corporation (Source: ...
Source: Funding opportunities via the Rural Health Information Hub - August 20, 2019 Category: American Health Source Type: funding
Notice of Correction to Award Budget for RFA-DA-19-020 " HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R41/R42 - Clinical Trial Optional)"
Notice NOT-DA-19-067 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 8, 2019 Category: Research Source Type: funding
Notice of Correction to Award Budget for RFA-DA-19-019 " HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R43/R44 - Clinical Trial Optional)"
Notice NOT-DA-19-057 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 8, 2019 Category: Research Source Type: funding
Technologies to Advance Precision Medicine Diagnosis and Treatment of Infertility, Reproductive Tract and Gynecologic Disorders Affecting Fertility (R43/R44 Clinical Trial Optional)
Funding Opportunity RFA-HD-20-010 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to encourage small businesses to collaborate with scientists and clinicians in the fields of female and male reproductive health, infertility, andrology, and/or gynecology to adapt discoveries in omics technologies such as genomics, epigenomics and metabolomics, as well as identification of disease biomarkers to the development of new devices, assays, digital apps, or technologies to improve the specificity of diagnosis and clinical care of infertility and to advance the application of precision medicine to reproduc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 7, 2019 Category: Research Source Type: funding
Notice of Special Interest for Small Business Research for Methods Development in Natural Products Chemistry
Notice NOT-AT-19-025 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 6, 2019 Category: Research Source Type: funding
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Required
Funding Opportunity PAR-19-335 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from small business concerns (SBCs) to the newly re-authorized Commercialization Readiness Pilot (CRP) program. The FOA aims to facilitate the transition of previously or currently funded SBIR and STTR Phase II and Phase IIB projects to the commercialization stage by providing additional support for technical assistance and later stage research and development (R and D) not typically supported through Phase II or Phase IIB grants or contracts. This may includ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 5, 2019 Category: Research Source Type: funding
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed
Funding Opportunity PAR-19-334 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from small business concerns (SBCs) to the newly re-authorized Commercialization Readiness Pilot (CRP) program. The FOA aims to facilitate the transition of previously funded SBIR and STTR Phase II and Phase IIB projects to the commercialization stage by providing additional support for technical assistance not typically supported through Phase II or Phase IIB grants or contracts. This may include preparation of documents for a Food and Drug Administration (F...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 5, 2019 Category: Research Source Type: funding
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Not Allowed
Funding Opportunity PAR-19-333 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from small business concerns (SBCs) to the newly re-authorized Commercialization Readiness Pilot (CRP) program. The FOA aims to facilitate the transition of previously or currently funded SBIR and STTR Phase II and Phase IIB projects to the commercialization stage by providing additional support for technical assistance and later stage research and development (R and D) not typically supported through Phase II or Phase IIB grants or contracts. This may includ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 5, 2019 Category: Research Source Type: funding
